Our Senior Scientist Gene Editing, Caitlin Collin, is at #CRISPRMED24 in Copenhagen! SparingVision is keen to engage with the latest in gene editing and therapy.

Looking forward to a fruitful exchange of ideas and advancements!

crisprmedicinenews.com/crisprmed24/

💬 In one week our CMO Daniel Chung, DO, MA will be in Basel 🇨🇭 for the BioPharma Clinical Trials Nexus where he will be participating in 3 panel discussions. Watch below for more details on the panels ⬇️

nexus-conference.com/ctneu/

#GenomicMedicines #Ophthalmology #ClinicalTrials

Today, our CMO Daniel C. Chung, DO, MA will be presenting at the BioLabs Investor Day in Philadelphia at The Curtis.

We hope to see you there!

biolabsinvestorday.com/philadelphia-24

#BioLabs #SparingVision #CellandGene #Genetherapy #Ophthalmology #InvestorDay

Our Supplies and Sample Manager, Lucile Bauché will be on the ground in Munich next week attending the Precision in Pharma Supply Chain & Logistics Summit from 15-16 April.

events.precision-globe.com/single-event/p…

#SparingVision #Genetherapy #Ophthalmology

It has been a couple of wonderful and insightful days this week in Rome for Alliance for Regenerative Medicine (ARM)'s annual Cell and Gene Meeting on the Med. Thanks to the organizers for another great event, looking forward to the next one! 👏

💥 We are presenting posters at two upcoming conferences: the ARVO 2024 Annual Meeting (5-9 May) and the ASGCT 27th Annual Meeting (7-11 May)! 🌟Be sure to catch the SparingVision team at the sessions shown below ⬇️
sparingvision.com/sparingvision-…

Tomorrow, our CMO Daniel Chung will be presenting at the @AllianceRM’s Cell & Gene Meeting on the Med in Rome.

He will be discussing updates from SparingVision at 2:00pm CEST in Salone dei Cavalierim, Section 2. We hope to see you there!

meetingonthemed.com

As #WorldHealthDay approaches, we're reminded that health is a universal right. Our work in gene therapy for ocular diseases at SparingVision aims to ensure this. Let's make #MyHealthMyRight a reality for all, especially those facing challenges with their sight.

Next week our team will be in Rome 🇮🇹 for Alliance for Regenerative Medicine (ARM)'s annual Cell and Gene #MeetingOnTheMed from 9-11 April.

Meet with our CMO, Daniel Chung, CR&QO, Marie Uguen and VP CorpDev, Rafaella Toso to learn more about SparingVision.

meetingonthemed.com

#SparingVision

That’s a wrap on the the 7th Annual Gene Therapy for Rare Disorders Summit Conference in Boston! 🎉
We return energized from having the opportunity to share our pioneering approach in ocular gene therapy
with key industry experts💥
#genetherapy #genomicmedicines

👁️ #SaveYourVision Month may be coming to an end, but we’re still working hard developing genomic medicines and bring relief to inherited retinal disease ( #IRD ) patients 🧬

➡️ Learn more here: sparingvision.com

#GenomicMedicines #Ophthalmology #GeneTherapy #GenomeEditing

We’re growing our team! 💼

Applications are now open for a Manager/Senior Manager role in our Regulatory Affairs team. Please apply via the link below.

linkedin.com/jobs/view/3873…

#hiring #openposition #regulatoryaffairs #genetherapy #ophthalmology

💡 Next week, our team will be busy in Boston for the 7th Annual Gene Therapy for Rare Disorders Summit. Be sure to catch our CMO, Daniel C. Chung, DO, MA, at the sessions shown below! ⬇️

genetherapy-conference.com/?utm_source=di…

#GenomicMedicines #Ophthalmology #GeneTherapy #GenomeEditing

🌟 Later this month we’ll be in Boston for the Gene Therapy for Rare Disorders Summit between 26-27 March! We’re looking forward to meeting other industry leaders there! 💪

#GenomicMedicines #Ophthalmology #GeneTherapy #GenomeEditing

🌟 Happy #InternationalWomensDay24 ! 🌍💪

🚀 To celebrate, our Board members share their insights and encouragement for women in healthcare & science who are making a positive impact on society.

👉 Read more: internationalwomensday.com

🇺🇸 Today is the start of #SaveYourVision Month in the US, an initiative dedicated to promoting the significance of regular eye check-ups to detect ocular diseases early, including retinitis pigmentosa ( #RP ) and age-related macular degeneration. 📣

#GenomicMedicines #GeneTherapy

📅 On the rarest day of the calendar year, the world marks #RareDiseaseDay . We are reminded of our commitment to developing a safe and effective treatment for patients with #retinitisPigmentosa (RP), a group of rare eye diseases that affect the retina 👁️

sparingvision.com

💡 Don’t miss our CEO Stephane Boissel’s presentation at the #EvercoreISI 2024 Emerging Biotech Conference tomorrow at 9:35am ET/3:35pm CET. Learn how we’re pioneering genomics to save sight! 👁️🧬

#GenomicMedicines #Ophthalmology #GeneTherapy #GenomeEditing

Thanks for having us, California! 🏄

#ICYMI 🌟 Earlier this month, we presented clinical data for #SPVN06 for the first time at the Macula Society 47thAnnual Meeting held in Palm Springs. 👁️

Read the full release here: sparingvision.com/sparingvision-…

#GenomicMedicines #GeneTherapy

🏝️ This week, Daniel Chung is in Bali for 39th Asia-Pacific Academy of #Ophthalmology Congress 🌏.

Dan will be delivering a presentation titled ‘Update of Retina Gene Therapy: The Breakthrough, the Challenges and the Future’. 👁️

2024.apaophth.org